Patents by Inventor Mark Edgar

Mark Edgar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7871179
    Abstract: An adjustable mount for a flashlight. The adjustable mount having a flashlight receiving body adapted to receive a flashlight. The adjustable mount having a connecting body rotatably connected to the flashlight receiving body at a right angle such that the flashlight receiving body rotates about the connecting body at the connection between the flashlight receiving body and the connecting body. The adjustable mount having a support body rotatably connected to the connecting body at a right angle such that the support body rotates about the connecting body at the connection between the support body and the connecting body.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: January 18, 2011
    Inventor: Mark Edgar
  • Patent number: 7434954
    Abstract: An adjustable mount for a flashlight. The adjustable mount having a flashlight receiving body adapted to receive a flashlight. The adjustable mount having a connecting body rotatably connected to the flashlight receiving body at a right angle such that the flashlight receiving body rotates about the connecting body at the connection between the flashlight receiving body and the connecting body. The adjustable mount having a support body rotatably connected to the connecting body at a right angle such that the support body rotates about the connecting body at the connection between the support body and the connecting body.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: October 14, 2008
    Inventor: Mark Edgar
  • Publication number: 20070010486
    Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.
    Type: Application
    Filed: May 3, 2006
    Publication date: January 11, 2007
    Inventors: Jeff Schwegman, Mark Edgar, Branimir Sikic, Daniel Hoth, David Socks, Scott Glenn, John Marcelletti, Michael Walsh, Pratik Multani
  • Publication number: 20070010487
    Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.
    Type: Application
    Filed: May 3, 2006
    Publication date: January 11, 2007
    Inventors: Jeff Schwegman, Mark Edgar, Branimir Sikic, Daniel Hoth, David Socks, Scott Glenn, John Marcelletti, Michael Walsh, Pratik Multani
  • Publication number: 20070010485
    Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.
    Type: Application
    Filed: May 3, 2006
    Publication date: January 11, 2007
    Inventors: Jeff Schwegman, Mark Edgar, Branimir Sikic, Daniel Hoth, David Socks, Scott Glenn, John Marcelletti, Michael Walsh, Pratik Multani